DexCom Inc (DXCM)
Payables turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 2,533,400 | 2,069,300 | 1,582,600 | 1,269,300 | 1,069,300 |
Payables | US$ in thousands | 276,400 | 237,900 | 196,000 | 163,300 | 102,300 |
Payables turnover | 9.17 | 8.70 | 8.07 | 7.77 | 10.45 |
December 31, 2023 calculation
Payables turnover = Cost of revenue ÷ Payables
= $2,533,400K ÷ $276,400K
= 9.17
The payables turnover ratio for Dexcom Inc has fluctuated over the past five years. In 2019, the ratio was 5.32, indicating that the company paid its suppliers approximately 5.32 times during that year. The ratio decreased to 3.96 in 2020 before gradually increasing to 4.82 in 2023. This suggests that Dexcom Inc has been managing its accounts payable more efficiently in recent years, as it took less time to pay off its suppliers. A higher payables turnover ratio generally indicates that a company is paying its suppliers more quickly, which can be seen as a positive sign of strong liquidity and efficient working capital management. Overall, the trend in Dexcom Inc's payables turnover ratio shows improving efficiency in managing its accounts payable obligations.
Peer comparison
Dec 31, 2023